Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation01:06

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

METTL3-Mediated m6A Modification of FYN: Regulating Tumor-Associated Endothelial Cells in Colorectal Cancer Progression.

Journal of gastroenterology and hepatology·2026
Same author

Exacerbation of sensory dysfunction by hematoma-induced circuitry damage in a mouse model of thalamic hemorrhage.

Brain research·2026
Same author

Up-regulation of miR-548 m Leading to Neuroinflammation to Promote the Progression of Alzheimer's Disease.

Molecular neurobiology·2026
Same author

TUDCA Ameliorates Cognitive Impairment in APP/PS1 Mice by Modulating the Microbiota-Gut-Brain Axis.

Current issues in molecular biology·2026
Same author

Chemical characterization and improvement property of Hydnocarpus wightianus-synthesized iron nanoparticles on lung infection in mice model.

Discover nano·2026
Same author

Conserved Sequence-Derived from Keratins Guides Design of Self-Assembling Protein for Accelerated Wound Healing.

Advanced healthcare materials·2026

Related Experiment Video

Updated: Jun 29, 2026

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

A novel hemostatic model with triple protective functions.

Jing Sui1, Bochu Wang, Zhengwen Yu

  • 1College of Bioengineering, Chongqing University, Chongqing 400030, People's Republic of China.

Medical Hypotheses
|October 15, 2008
PubMed
Summary
This summary is machine-generated.

This study introduces a novel hemostatic model integrating essential oils with hemostatic agents. This triple-action approach aims to improve wound bleeding control and prevent infection.

More Related Videos

A Novel In vitro Model for Studying the Interactions Between Human Whole Blood and Endothelium
06:27

A Novel In vitro Model for Studying the Interactions Between Human Whole Blood and Endothelium

Published on: November 21, 2014

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Related Experiment Videos

Last Updated: Jun 29, 2026

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

A Novel In vitro Model for Studying the Interactions Between Human Whole Blood and Endothelium
06:27

A Novel In vitro Model for Studying the Interactions Between Human Whole Blood and Endothelium

Published on: November 21, 2014

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Area of Science:

  • Biomaterials Science
  • Wound Healing Research
  • Infectious Disease Prevention

Background:

  • Hemostatic agents are crucial for controlling bleeding, but often neglect infection prevention.
  • Essential oils show promise as antimicrobial agents, offering potential for wound care.
  • A dual-function hemostatic and antimicrobial wound dressing is needed.

Purpose of the Study:

  • To design and hypothesize a novel hemostatic model with triple protective functions.
  • To integrate essential oils with hemostatic ingredients for enhanced wound management.
  • To explore the potential of this model in treating external bleeding wounds.

Main Methods:

  • Coordinating essential oils with traditional hemostatic ingredients.
  • Utilizing the natural evaporation of essential oils to form a protective wound layer.
  • Leveraging the inherent antimicrobial properties of plant-derived essential oils.

Main Results:

  • The proposed model provides hemostasis during hemorrhage.
  • Essential oils form a protective barrier, preventing pathogenic bacterial infection.
  • Essential oils offer adjunctive treatment for established wound infections.

Conclusions:

  • The novel hemostatic model offers triple protective functions: hemostasis, infection prevention, and antimicrobial activity.
  • This integrated approach presents broader therapeutic utility for external bleeding wounds compared to current hemostatic drugs.
  • Essential oil integration represents a promising strategy for advanced wound care solutions.